DANish Study of Optimal Acute Treatment of Patients With ST-elevation Myocardial Infarction (NCT01435408) | Clinical Trial Compass
UnknownNot Applicable
DANish Study of Optimal Acute Treatment of Patients With ST-elevation Myocardial Infarction
Denmark2,000 participantsStarted 2011-04
Plain-language summary
This study focuses on Cardioprotective strategies.
Who can participate
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age ≥ 18 years.
* Acute onset of chest pain of \< 12 hours' duration.
* ST-segment elevation ≥ 0.1 mV in ≥ 2 contiguous leads, signs of a true posterior infarction or documented newly developed left bundle branch block.
Culprit lesion in a major native vessel.
Exclusion Criteria:
* Pregnancy.
* Known intolerance of ASA, clopidogrel, heparin or contrast.
* Inability to understand information or to provide informed consent.
* Haemorrhagic diathesis or known coagulopathy.
* Stent thrombosis.
What they're measuring
1
All cause mortality, heart failure (postconditioning)